ScriptaJun 21, 2017PCSK9 Inhibitors | Worth It? For Whom?June 19, 2017 – Big Pharma, insurers, and doctors engage debate over efficacy and cost; meanwhile, patients struggle to access to an...
ScriptaJun 9, 2017FEUD! Big Pharma vs. Your PBMMay 31, 2017 – In a lawsuit that highlights the dangers of rising drug costs, PMBs and drugmakers reveal the games the games they play....
ScriptaMay 22, 2017Big Pharma Loves to Create DramaMay 18, 2017 – The FDA regulates direct-to-consumer marketing of pharmaceutical products, but it does not regulate “Disease Awareness”...
ScriptaJan 6, 2017EpiPen Price Gouging No BetterJUNE 6, 2017 – A YEAR AGO, CONSUMERS AND CONGRESSMEN ALIKE WERE SHOCKED WHEN MYLAN RAISED THE PRICE OF ITS EPIPEN BY 574%. NOTHING HAS...
ScriptaDec 26, 2016A 75% Markup for Being AmericanDecember 24, 2016 – America has always been known as “The Land of Opportunity.” New data shows that this is especially true for drug...
ScriptaDec 22, 2016Specialty Pharma Takes a HitDECEMBER 22, 2016 – ANALYSTS EXPECT MORE UNCERTAINTY FOLLOWING A YEAR IN WHICH THE MARTIN SHKRELI, EPIPEN, AND VALEANT SCANDALS BATTERED...